A study has shown that anti-TLR2 administration alleviated α-synuclein accumulation, neuroinflammation, and neurodegeneration in neurons and astrocytes in the α-synuclein high expression mouse model of PD [16]. Here, TLR2 is linked to Parkinson disease.